Vulnerability · Published Jan 20, 2026 · Assigned by oracle

CVE-2026-21980

Medium 6.5

In plain English

A medium-severity security flaw in Oracle Life Sciences Central Coding from Oracle Corporation. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.2% (higher than 12% of all known vulnerabilities).

Severity (CVSS 3.1)6.5Medium

Exploit odds (30 days)0.2%top 87.7% of all CVEs

Exploited in the wildNo reportsCISA SSVC: none

Attack toolingNoneno public tooling known

Official description

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

Affected products (as reported)

Vendor	Product	Versions
Oracle Corporation	Oracle Life Sciences Central Coding	7.0.1.0

References

Oracle Advisory vendor-advisory